NYNClass II

Stimulator, Electrical, Transcutaneous, For Arthritis

21 CFR 882.5890 / Neurology

NYN is the FDA product code for Stimulator, Electrical, Transcutaneous, For Arthritis, a class II device type, regulated under 21 CFR 882.5890. FDA's definition for this code reads: "Electrical stimulation unit with leads and cutaneous electrodes used to apply an electrical current through electrodes on patient's skin to provide relief of pain associated with arthritis (including osteoarthritis and rheumatoid arthritis)". As of 2026-09-10, FDA records hold 8 510(k) clearances under this code, the most recent dated 2015-03-23, and no recalls.

Classification record

Product code: NYN
Device name: Stimulator, Electrical, Transcutaneous, For Arthritis
FDA definition: Electrical stimulation unit with leads and cutaneous electrodes used to apply an electrical current through electrodes on patient's skin to provide relief of pain associated with arthritis (including osteoarthritis and rheumatoid arthritis).
Regulation: 21 CFR 882.5890
Device class: Class II
Review panel: Neurology
Submission type: 510(k)
Implant: No
Life sustaining or supporting: No
GMP exempt: No
Third party review eligible: Yes
Ingested clearances: 8
Ingested recalls: 0

Clearances, product code NYN

By decision year

8 clearances under product code NYN with a decision year between 1997 and 2015, 1997 the highest year at 1.

Show the numbers

510(k) clearances under FDA product code NYN by decision year
Year	Clearances
1997	1
1999	1
2003	1
2005	1
2007	1
2008	1
2011	1
2015	1

Applicants with the most clearances

Product code NYN

Applicants holding the most 510(k) clearances under product code NYN
Applicant	Clearances
Bionicare Medical Technologies, Inc.	2
Murray Electronics	2
Pain Management Technologies	1
RS Medical	1
Seven Seas Distribtion and Manufacturing, LLC	1
Vision Quest Industries, Inc.	1

Companies listing this code with FDA

Companies whose registered establishments list this code

12 of 67 companies shown, in name order